From Narcotic to Normalizer: The Misperception of Methadone Treatment and the Persistence of Prejudice and Bias

Woods, Joycelyn Sue; Joseph, Herman

doi:10.1080/10826084.2017.1400068

Cited by 19 publications

(12 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The misconception that opioid addiction is a choice increases the likelihood of social rejection and the risk of relapse of MAT patients. 10 The fact that this study indicated that a 24-hour educational process could be instrumental in challenging and transforming attitudes toward those with opioid addiction has important implications for addiction medicine training.…”

Section: Discussionmentioning

confidence: 91%

Shifts in Attitudes and Intentions to Practice Following Medication-Assisted Treatment Training

Phelps

Rodríguez

Alvarez

et al. 2021

J Physician Assist Educ

View full text Add to dashboard Cite

Assistant (PA) program was one of the first PA programs in the country to incorporate medication-assisted treatment (MAT) into its curriculum. This manuscript documents the impact of the course. MethodsIn the spring and summer of 2018, 61 students and 12 local providers enrolled in an elective MAT course developed by Idaho State University. All completed the training. At the end of the course, only the students submitted reflective essays.Results A review and coding of the essays indicated that MAT education increased knowledge about addiction and resulted in self-reported decreases in negative attitudes towards people with addictions.Conclusion PA programs can support communities' increased capacity to offer MAT. A widely available course appears to result in important gains in both knowledge and attitude.

show abstract

Section: Discussionmentioning

confidence: 91%

Shifts in Attitudes and Intentions to Practice Following Medication-Assisted Treatment Training

Phelps

Rodríguez

Alvarez

et al. 2021

J Physician Assist Educ

View full text Add to dashboard Cite

show abstract

“…Regarding physical impairment, methadone maintenance patients showed greater di culty and impaired psychomotor skills in compared with buprenorphine [9]. However, it is important to stress that methadone remains as a safe pro le for its use in opiate-addicted patients [7,42].…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Functional Status Among Patients Undergoing Maintenance Treatments for Opioid use Disorders

Ruíz¹,

Delgado²,

García-Marchena

et al. 2020

Preprint

View full text Add to dashboard Cite

Objective Methadone and buprenorphine are the most prevalent types of opioid maintenance programs in Andalusia. The main objective is comparing the functional and health status of patients with pharmacological opioid maintenance treatments according to different socio-demographic characteristic, disabilities and sexual functioning difficulties. Methods A total of 593 patients from the Andalusia community, 329 were undergoing methadone treatment and 264 were undergoing buprenorphine treatment. The patients were interviewed by socio-demographic and opioid-related variables, assessed by functional disability and health variables ( WHODAS 2.0. ) and for sexual dysfunction ( PRSexDQ-SALSEX ). Results We found significant differences in the socio-demographic and the opioid-related variables as the onset of opioid use, being on previous maintenance programs, opioid intravenous use, the length of previous maintenance programs, polydrug use and elevated seroprevalence rates (HCV and HIV) between the methadone group and the buprenorphine group. There were differences in the Understanding and communication domain, Getting around domain, Participation in society domain and in the WHODAS 2.0. simple and complex score, favoring buprenorphine-treated patients. The methadone group had elevated sexual dysfunction than the buprenorphine group. Opioid-related variables as seroprevalence rates, other previous lifetime maintenance program, the daily opioid dosage and the daily alcohol use are the most discriminative variables between both groups. Participation in society variables and sexual problems were the most important clinical variables in distinguishing the methadone group from the buprenorphine group. Conclusions The methadone group showed higher prevalence in opioid dependence-related variables, elevated disabilities in participation in society activities and sexual problems compared with the buprenorphine group.

show abstract

“…Methadone is extensively studied and is an effective treatment for OUD [ 34 ]. One benefit identified from the patient’s perspective is that the individual might soon return to their typical daily routine, shortly after initiation of methadone treatment [ 35 ]. Previous studies explored various barriers to methadone adherence, concluding that one of the main impediments for patients is attending the clinic daily to receive treatment [ 36 , 37 ] In contrast, one of the main benefits of buprenorphine and buprenorphine/naloxone treatment is that the individual can take the treatment at home.…”

Section: The Vicious Cycle Of Opioid Use Disorder In the Plwha Popmentioning

confidence: 99%

Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders

et al. 2020

View full text Add to dashboard Cite

The opioid epidemic has had a significant, negative impact in the United States, and people living with HIV/AIDS (PLWHA) represent a vulnerable sub-population that is at risk for negative sequela from prolonged opioid use or opioid use disorder (OUD). PLWHA are known to suffer from HIV-related pain and are commonly treated with opioids, leading to subsequent addictive disorders. PLWHA and OUD are at an increased risk for attrition in the HIV care continuum, including suboptimal HIV laboratory testing, delayed entry into HIV care, and initiation or adherence to antiretroviral therapy. Barriers to OUD treatment, such as medication-assisted therapy, are also apparent for PLWHA with OUD, particularly those living in rural areas. Additionally, PLWHA and OUD are at a high risk for serious drug–drug interactions through antiretroviral-opioid metabolic pathway-related inhibition/induction, or via the human ether-a-go-go-related gene potassium ion channel pathways. HIV-associated neurocognitive disorders can also be potentiated by the off-target inflammatory effects of opioid use. PLWHA and OUD might require more intensive, individualized protocols to sustain treatment for the underlying opioid addiction, as well as to provide proactive social support to aid in improving patient outcomes. Advancements in the understanding and management of PLWHA and OUD are needed to improve patient care. This review describes the effects of prescription and non-prescription opioid use in PLWHA.

show abstract

From Narcotic to Normalizer: The Misperception of Methadone Treatment and the Persistence of Prejudice and Bias

Cited by 19 publications

References 27 publications

Shifts in Attitudes and Intentions to Practice Following Medication-Assisted Treatment Training

Shifts in Attitudes and Intentions to Practice Following Medication-Assisted Treatment Training

Evaluation of Functional Status Among Patients Undergoing Maintenance Treatments for Opioid use Disorders

Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders

Contact Info

Product

Resources

About